Skip to main navigation menu Skip to main content Skip to site footer
JASBB Baner text

Vol. 36 No. 3 (2018)

Articles

Environmental health risks on the example of hepatitis C virus in the area of PSSE in Końskie activity

DOI: https://doi.org/10.24326/jasbbx.2018.3.4
Submitted: December 20, 2018
Published: 2018-09-20

Abstract

The hepatitis C virus is currently considered to be the main challenge to the public health. The long-lasting and symptoms-free course of the infection makes it very difficult to detect and diagnose. The purpose of this work is to present the characteristics of the occurrence of hepatitis C virus among the people living in Koniecki County. The research was carried out in 2017 and included numerical data for 2013–2015. The data comes from the County Sanitary-Epidemiological Station in Końskie and contains all cases of hepatitis C reported at the station. The reported cases were analysed with respect to age, sex and place of residence. During the study there were 13 recorded cases of hepatitis C virus in the area of CSES in Końskie. All the patients were adults, 30–59 years old. Among them there were 4 people who lived in a city while the rest were from countryside areas. As far as the number of people infected is concerned, during the duration of the research the percentage ranged from 0.02 to 0.09%, which shows a low coefficient value, compared with 1–6% in western countries.

References

  1. Bogucki M., Flisiak R., Halota W., Jaworska U., Kozierkiewicz A., Kruszewski J., Małecka-Libera B., Matusiewicz W., Pepke B., Raciborski F., Smoliński B., 2012. Raport rekomendacje 2013–2014. Diagnostyka i terapia przewlekłego wirusowego zapalenia wątroby typu C (wirusem HCV) w Polsce, 5–50.
  2. Cieśla A., Mach T., 2007. Chronic viral hepatitis – current epidemiological, clinical and therapeutic challenge. Przegl. Gastroenterol. 2(2), 69–73.
  3. Esteban J.I., Sauleda S., Quer J., 2008. The changing epidemiology of hepatitis C virus infection in Europe. J. Hepatol. 48(1), 148–162.
  4. EASL, European Association for the Study of the Liver. 2014a. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J. Hepatol. 60, 392–420.
  5. EASL, European Association for the Study of the Liver (EASL), 2014b. Recommendations on Treatment of Hepatitis C. http://files.easl.eu/easl-recommendations-on-treatment-of-hepatitis-C.pdf.
  6. ECDC, European Centre for Disease Prevention and Control. Surveillance of hepatitis B and C in Europe. 2012. http://ecdc.europa.eu/en/publications/Publications/hepatitis-b-c-surveillance-europe-2012-july-2014.pdf.
  7. ECDC, European Centre for Disease Prevention and Control: Annual epidemiological report Sexually transmitted infections, including HIV and blood-borne viruses. 2014. http://ecdc.europa.eu/en/publications/Publications/sexually-transmited-infections-HIV-AIDS-blood-borne-annual-epi-report-2014.pdf.
  8. Gower E., Estes C., Blach S., 2014. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 30, 45–57.
  9. Jabłoński L., Karwat I.D., 2002. Podstawy epidemiologii ogólnej, epidemiologia chorób zakaźnych. Czelej, Lublin, 305–319.
  10. Juszczyk J., 2009. Wirusowe zapalenie wątroby typu C – podstawowe fakty od rozpoznania do leczenia. Vioce 1(19), 3–9.
  11. Juszczyk J., 2004. Hepatitis C: to co najważniejsze. Przew. Lekarza 10, 74–79.
  12. Kahana S., 2004. Medycyna w pigułce. Via Media, Gdańsk, 74–78.
  13. Madaliński K., Zakrzewska K., Kołakowska A., Godzik P., 2015. Epidemiologia zakażeń HCV w Europie środkowej i wschodniej. Przegl. Epidemiol. 69, 581–584.
  14. Magdzik W., Naruszewicz-Lesiuk D., Zieliński A., 2004. Choroby zakaźne i pasożytnicze – epidemiologia i profilaktyka. Į-medica press, Bielsko-Biała, 325–343.
  15. Morel V., Fournier C., François C., Brochot E., Helle F., Duverlie G., Castelain S., 2011. Genetic recombination of the hepatitis C virus: clinical implications. J. Viral Hepatitis 18(2), 77–83.
  16. Parda N., Henszel Ł., Stępień M., 2014. Wirusowe zapalenie wątroby typu C w Polsce w 2012 roku. Przegl. Epidemiol. 68, 369.
  17. Pawlotsky J.M., Aghemo A., Dusheiko G., Forns X., Puoti M., Sarrazin C., 2014. EASL recommendations on treatment of hepatitis C – 2014. J. Hepatol. 61(2), 373–95.
  18. Polański J.A., 2004. Hepatologia. Medical Tribune Group, Warszawa, 57–63.
  19. Simon K., Szymczak A., 2005. Wirusologia molekularna a leczenie przewlekłych zapaleń wątroby typu C. Przegl. Epidemiol. 59, 503–510.
  20. Stępień M., Rosińska M., 2015. Ogniska wirusowego zapalenia wątroby typu C w Polsce w latach 2003–2013. Procedury medyczne najczęstszą drogą przenoszenia zakażeń HCV. Przegl. Epidemiol. 69, 585–590.
  21. Thimme R., Neumann-Haefelin C., Spangenberg H.C., Blum H.E., 2006. Virushepatitis A–E. Gastroenterologe 1, 61–74.
  22. WHO, 2010. The 63rd World Health Assemby. Resolutions and Decisions Annexes. World Health Organization. http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf.
  23. WHO, 2014a. Guidelines for the screening, care and treatment of persons with hepatitis C infection. World Health Organization.
  24. WHO, 2014b. Sixty-Seventh World Health Assembly, Hepatitis. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R6-en.pdf?ua=1.
  25. WHO, 2017. Hepatitis C fact sheet No 164. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index2.html.
  26. Wiersma S., 2011. The global burden of disease of viral hepatitis. Viral Hepatitis 19, 9–10.
  27. Władysiuk M., Jaros P., Kobierski J., Hałdaś M., Gąszcz K., Krzystek J., 2014. WZW typu C. Konieczność zmian w organizacji systemu ochrony zdrowia. HTA Consulting, Kraków, 5–20.

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.